Loading data for ACXP — first visit, this takes a few seconds.
Acurx Pharmaceuticals Inc... (ACXP)
NasdaqCM: ACXP
· Real-Time Price · USD
1.40
-0.07 (-4.76%)
At close: Aug 24, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Acurx Pharmaceuticals Inc. (ACXP) Stock Price, Analysis & Data
-4.76% (1D)
No data available
| Bid | 1.05 |
| Market Cap | 6.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.51M |
| -2.03 | |
| -2.44 | |
| n/a | |
| -0.8 | |
| P/B (ttm) | 0.80 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 11, 2026 |
| Ask | 1.81 |
| Volume | 132,545 |
| Avg. Volume (20D) | 123,479 |
| Open | 1.47 |
| Previous Close | 1.47 |
| Day's Range | 1.40 - 1.49 |
| 52-Week Range | 1.31 - 8.34 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ACXP
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-pos...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 25, 2021
Employees 4
Stock Exchange NasdaqCM
Ticker Symbol ACXP
Website https://www.acurxpharma.com
Financial Performance
In 2025, Acurx Pharmaceuticals's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -7.97M, a decrease of -43.51%.
Financial StatementsEarnings Surprise
Acurx Pharmaceuticals has released their quarterly earnings on Aug 13, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.53 misses estimates by -0.10, with 71.96% YoY growth.
Acurx Pharmaceuticals Inc. is scheduled to release its earnings on Nov 11, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2
